Highbridge Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History
Bought
Maintained
Sold
Other funds holding DALS
Highbridge Capital Management's DALS Position: Q4 2022 in Review
Highbridge Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q4 2022, closing a stake of 90,891 shares — an estimated $881K sold.
Highbridge Capital Management first reported a position in DALS in Q3 2022 and held it in 1 quarter. The position peaked at $881K in Q3 2022. 47 funds tracked by Wall St. Rank hold DALS as of Q4 2022.
- Highbridge Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q4 2022 after selling out during the quarter.
- Highbridge Capital Management sold 90,891 DA32 Life Science Tech Acquisition Corp shares in Q4 2022, an estimated $881K.
- Highbridge Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2022 and held it in 1 quarter.
- Highbridge Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $881K in Q3 2022.
- 47 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q4 2022.
Based on Highbridge Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.